VaccineImmunologyPeer-reviewed journal article
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases
Joel FinneyiD, Masayuki KuraokaiD, Shengli SongiD, Akiko WatanabeiD, Xiaoe Liang, Dongmei Liao, Michael Anthony MoodyiD, Emmanuel B. WalteriD, Stephen C. HarrisoniD, Garnett H. KelsoeiD
Abstract
The discovery of broadly protective antibodies to the influenza virus neuraminidase (NA) has raised interest in NA as a vaccine target. However, recombinant, solubilized tetrameric NA ectodomains are often challenging to express and isolate, hindering the study of anti-NA humoral responses. To address this obstacle, we established a panel of 22 non-adherent cell lines stably expressing native, historical N1, N2, N3, N9, and NB NAs anchored on the cell surface. The cell lines are barcoded with fluorescent proteins, enabling high-throughput, 16-plex analyses of antibody binding with commonly available flow cytometers. The cell lines were at least as efficient as a Luminex multiplex binding assay at identifying NA antibodies from a library of unselected clonal IgGs derived from human memory B cells. The cell lines were also useful for measuring the magnitude and breadth of the serum antibody response elicited by experimental infection of rhesus macaques with influenza virus. The membrane-anchored NAs are catalytically active and are compatible with established sialidase activity assays. NA-expressing K530 cell lines therefore represent a useful tool for studying NA immunity and evaluating influenza vaccine efficacy.
- organism: human
- organism: rat
- assay: flow cytometry
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 10th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Membrane-anchored influenza neuraminidase vaccine drives human-like broadly protective B cell responses
Rui Liu, Chaohui Lin, … Zeli Zhang·bioRxiv·May 15, 2026
- Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants
Kirill Vasilev, Irene Hoxie, … Florian Krammer·bioRxiv·Feb 26, 2025
- Elucidating the Characteristics and Clonal Evolutionary Trajectory of Influenza Neuraminidase Broadly Reactive B Cell
Chaohui Lin, Qian Yang, … Zeli Zhang·Science AdvancesPeer-reviewed·Aug 1, 2025
- Monoclonal antibodies targeting the influenza virus N6 neuraminidase
S. Strohmeier, F. Amanat, … F. Krammer·bioRxiv·Feb 15, 2021
- Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
P. Rijal, B. B. Wang, … K.-Y. A. Huang·bioRxiv·Jun 26, 2019
- Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation
Xueyong Zhu, Ahmed Magdy Khalil, … James J. Kobie·Communications BiologyPeer-reviewed·Oct 6, 2025